FDA Approves Injectable Form of GSK HIV Prevention Drug

The U.S. Food and Drug Administration (FDA) on Monday approved an injectable form of GlaxoSmithKline Plc’s cabotegravir drug that is given every two months to prevent an HIV infection. Read More